Endonuclease-mediated disruption of latent HSV as curative therapy

$154,968R01FY2021AINIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Keith R Jeromecontact

Linked publications, trials & patents

Paper 38740820 Paper 38700354 Paper 38445887 Paper 37503290 Paper 37165032 Paper 33892762 Paper 32851652 Paper 32811834 Paper 31916032

View original record on NIH RePORTER →